June's Latest News and updates from DrugBank
Welcome to this month's edition of the DrugBank Data Digest, where we bring you the latest insights and updates from the forefront of pharmaceutical research and innovation.
Lantern Pharma's Pioneering Role in AI-Driven Oncology Drug Development with the RADR? Platform
See how RADR? is revolutionizing oncology drug development and positioning with greater precision and reduced costs and timelines
From Nanotechnology to Gene Therapy: Innovations in Drug Delivery
Explore how advanced drug delivery systems are enhancing efficacy and minimizing side effects in modern medicine.?
From Impossible to Inevitable: Transforming Undruggable Targets
Delve into the challenges and innovative approaches of making undruggable targets druggable.
Drug Repurposing: A New Life for Old Drugs
Explore how repurposing drugs are proving to be the key to unlocking undruggable targets, faster trials, and reduced costs.
Product Updates
Standardized Clinical Trial Termination Reasons
Understanding why clinical trials stop and identifying patterns across trials is crucial for decision-making. We are pleased to announce the inclusion of Standardized Clinical Trial Termination Reasons for all trials in our database.
Structured Pharmacology
DrugBank continues to enhance the accessibility and machine readability of its data. We now offer more structured forms of our ADMET data, enabling quick retrieval and modeling. The values include Clearance, Half-Life, Volume of Distribution, Bioavailability, Cmax, Tmax, AUC, Route of Elimination, Protein Binding, Age Groups, and Sex.